Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Report: Hospira
May 1, 2013
Quality and product related charges contribute to losses   Read More »
Financial Report: Merck
May 1, 2013
Singulair expiry continues to impact results   Read More »
Financial Report: PAREXEL
May 1, 2013
Revenues up 27% in the quarter   Read More »
Financial Report: Pfizer
April 30, 2013
Revenues disappoint, but new products rise   Read More »
Financial Report: Bristol-Myers Squibb
April 26, 2013
Avapro, Plavix expirations pummel results   Read More »
Financial Report: AbbVie
April 26, 2013
Humira sales up 16% in first reporting quarter   Read More »
Financial Reports: AstraZeneca
April 25, 2013
Seroquel IR loss pummels revenues   Read More »
Financial Reports: Biogen Idec
April 25, 2013
MS franchise continues growth   Read More »
Financial Reports: Alexion
April 25, 2013
Soliris continues to rise   Read More »
Financial Reports: ICON
April 25, 2013
Revenues rise at CRO   Read More »
Financial Reports: Eli Lilly & Co.
April 24, 2013
Higher prices help offset Zyprexa losses   Read More »
Financial Reports: Amgen
April 24, 2013
Enbrel price increases offset unit decline   Read More »
Financial Reports: GlaxoSmithKline
April 24, 2013
Loss of Vesicare revenues hurts U.S. results   Read More »
Financial Reports: Novartis
April 24, 2013
Growth products offset Diovan loss   Read More »
Financial Report: Baxter
April 18, 2013
BioScience revenues up 5%   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: